[Federal Register Volume 65, Number 183 (Wednesday, September 20, 2000)]
[Notices]
[Pages 56913-56914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-24106]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Notice; Correction

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee notice correction.
    This notice announces the correction of previously announced 
meeting in the Federal Register: August 25, 2000 (Volume 65, Number 
166) [Notices--Page 51832]

ACTION: Notice; correction.

-----------------------------------------------------------------------

    Name: Clinical Laboratory Improvement Advisory Committee (CLIAC).
    Times and Dates:

8:30 a.m.--5 p.m., September 27, 2000
8:30 a.m.--3:30 p.m., September 28, 2000

    Place: CDC, Koger Center, Williams Building, Conference Rooms 1802 
and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 85 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the standards 
under which clinical laboratories are regulated; the impact of proposed 
revisions to the standards; and the modification of the standards to 
accommodate technological advances.
    Matters to be Discussed: This agenda has been updated since 
previously published on August 25, 2000. The agenda will include an 
orientation of new members. The morning session of the first day will 
be devoted to the orientation which consists of providing

[[Page 56914]]

background information on the Clinical Laboratory Improvement 
Amendments of 1988 (CLIA) program. The revised agenda also will include 
the workgroup report on specimens and test systems not currently 
regulated under CLIA, the criteria and process for waiver, and updates 
from CDC, Food and Drug Administration and Health Care Financing 
Administration.
    The Committee solicits oral and written testimony on specimens and 
test systems not currently regulated under CLIA. Requests to make an 
oral presentation should be submitted in writing to the contact person 
listed below by close of business, September 20, 2000. All requests to 
make oral comments should contain the name, address, telephone number, 
and organizational affiliation of the presenter.
    Written comments should not exceed five single-spaced typed pages 
in length and should be received by the contact person listed below by 
close of business, September 20, 2000.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR ADDITIONAL INFORMATION: Rhonda Whalen, Acting Chief, 
Laboratory Practice Standards Branch, Division of Laboratory Systems, 
Public Health Practice Program Office, CDC, 4770 Buford Highway, NE, 
Mailstop F-11, Atlanta, Georgia 30341-3724, telephone 770/488-8042, fax 
770/488-8279.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: September 6, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 00-24106 Filed 9-19-00; 8:45 am]
BILLING CODE 4163-18-P